These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 21974805)

  • 1. Galectin-3--a jack-of-all-trades in cancer.
    Newlaczyl AU; Yu LG
    Cancer Lett; 2011 Dec; 313(2):123-8. PubMed ID: 21974805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of galectin-3 in cancer apoptosis.
    Nakahara S; Oka N; Raz A
    Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDGF: a novel jack-of-all-trades in cancer.
    Bao C; Wang J; Ma W; Wang X; Cheng Y
    Future Oncol; 2014 Dec; 10(16):2675-85. PubMed ID: 25236340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 and cancer (Review).
    Califice S; Castronovo V; Van Den Brûle F
    Int J Oncol; 2004 Oct; 25(4):983-92. PubMed ID: 15375548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 and metastasis.
    Takenaka Y; Fukumori T; Raz A
    Glycoconj J; 2002; 19(7-9):543-9. PubMed ID: 14758078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunhistochemical expression of galectin-3 in cancer: a review of the literature.
    Cay T
    Turk Patoloji Derg; 2012; 28(1):1-10. PubMed ID: 22207425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling galectin-1 as a novel therapeutic target for cancer.
    Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
    Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 as a multifunctional protein.
    Krześlak A; Lipińska A
    Cell Mol Biol Lett; 2004; 9(2):305-28. PubMed ID: 15213811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 expression in colorectal cancer: relation to invasion and metastasis.
    Tsuboi K; Shimura T; Masuda N; Ide M; Tsutsumi S; Yamaguchi S; Asao T; Kuwano H
    Anticancer Res; 2007; 27(4B):2289-96. PubMed ID: 17695516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3.
    Califice S; Castronovo V; Bracke M; van den Brûle F
    Oncogene; 2004 Sep; 23(45):7527-36. PubMed ID: 15326483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 in angiogenesis and metastasis.
    Funasaka T; Raz A; Nangia-Makker P
    Glycobiology; 2014 Oct; 24(10):886-91. PubMed ID: 25138305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
    Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL
    Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner.
    Kim SJ; Chun KH
    BMB Rep; 2020 Apr; 53(4):173-180. PubMed ID: 32172730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.
    O'Driscoll L; Linehan R; Liang YH; Joyce H; Oglesby I; Clynes M
    Anticancer Res; 2002; 22(6A):3117-25. PubMed ID: 12530054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of galectin-3 in advancing thyroid cancer cells: a clue toward understanding tumour progression and metastasis.
    Htwe TT; Karim N; Wong J; Jahanfar S; Mansur MA
    Singapore Med J; 2010 Nov; 51(11):856-9. PubMed ID: 21140111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.
    Ito K; Stannard K; Gabutero E; Clark AM; Neo SY; Onturk S; Blanchard H; Ralph SJ
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):763-78. PubMed ID: 22706847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.
    Matarrese P; Fusco O; Tinari N; Natoli C; Liu FT; Semeraro ML; Malorni W; Iacobelli S
    Int J Cancer; 2000 Feb; 85(4):545-54. PubMed ID: 10699929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the interaction between galectin-3 and cell adhesion molecules in cancer metastasis.
    Xin M; Dong XW; Guo XL
    Biomed Pharmacother; 2015 Feb; 69():179-85. PubMed ID: 25661355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.
    Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S
    J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway.
    Alge-Priglinger CS; André S; Schoeffl H; Kampik A; Strauss RW; Kernt M; Gabius HJ; Priglinger SG
    Biochimie; 2011 Mar; 93(3):477-88. PubMed ID: 21094672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.